Genus plc (GENSF) Research

Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: Genus PIC, Genus ABS, and Genus Research and Development. Through its PIC brand, the company supplies breeding pigs and boar semen, enabling the production of swine with specific traits for pork processing. Furthermore, under the ABS, Genus, and Bovec labels, it provides bull semen and bovine embryos to facilitate the breeding of calves with targeted characteristics for dairy and beef output. Genus plc also extends specialized technical support to agricultural producers. Established in 1994, the company's headquarters are located in Basingstoke, United Kingdom.

Market snapshot

Symbol
GENSF
Price
$31.07
Day change
0.00%
Market cap
$1.5B
P/E ratio
30.69x
52-week range
26.01-37.25
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 3 months

Peer companies

  • Bonesupport Holding AB (publ) (BOEUF)
  • BioArctic AB (publ) (BRCTF)
  • CStone Pharmaceuticals (CSPHF)
  • Gerresheimer AG (GRRMF)
  • Green Thumb Industries Inc. (GTBIF)
  • Mesoblast Limited (MEOBF)
  • Neuren Pharmaceuticals Limited (NURPF)
  • Oxford Nanopore Technologies plc (ONTTF)

Open Genus plc (GENSF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.